Greater Occipital Nerve (GON) Block Effectivity in the Treatment of Chronic Migraine: 6 Months Follow up

• Status: Withdrawn
• Trial end date: 2018-07-01
• Target enrollment: 0
• Participant gender: All

Summary

This study evaluates effectiveness of greater occipital nerve blocks with bupivacaine compared to placebo in chronic migraine patients.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bozok University
• Treatments: Bupivacaine

Criteria

Inclusion Criteria:

• Chronic migraine headache according to International Headache Society Classification Criteria

• Patients who are not using any prophylacting agent

Exclusion Criteria:

• patients given similar treatments before

• pregnant women

• hereditary diseases causing bleeding

• patients who have intracranial tumor or operation in posterior fossa

• allergic reactions to local anesthetics.